Company intelligence / Profile preview

Invistics

Peachtree Corners / Atlanta area, Georgia, United Stateswolterskluwer.com ↗

Ownership: Private
Development stage: Commercial

Overview

Invistics developed Flowlytics, an NIH-funded cloud-based software using AI/machine learning to detect drug diversion and support compliance for controlled substances. The solution demonstrated over 90% accuracy in identifying real cases of drug diversion and was shown to outperform legacy solutions in speed and efficiency during a five-year NIH-funded study. The company was acquired by Wolters Kluwer Health in June 2023.

Therapeutic areas: Other
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

National Institutes of Health/National Institute on Drug Abuse grant fundingcustomers include major hospital systemspreviously worked with Shire/Patheon PharmaceuticalMeadWestvacoDupontBristol Myers Squibb for supply chain solutions pre-healthcare focus

Beyond the preview

Go deeper on Invistics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invistics.

Explore the full profile